QualityStocksNewsBreaks – KemPharm Inc. (NASDAQ: KMPH) Secures $52.4M in Follow-on and $44M in Warrant Exchange Transaction
KemPharm (NASDAQ: KMPH), a specialty pharmaceutical company focused on the discovery and development of proprietary prodrugs, has closed an underwritten public offering of 8,066,342 shares of its common stock (or pre-funded warrants to purchase common stock in lieu thereof) and accompanying warrants to purchase up to 8,066,342 shares of common stock. According to the update, this includes 374,035 additional shares of common stock and warrants pursuant to the partial exercise of the over-allotment option granted to the underwriters. KemPharm secured approximately $52.4 million in gross proceeds, with the shares of common stock (or pre-funded warrant in lieu thereof) sold together…